Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (401-410 of 927) with videos related to

Pageof 93
Sort By:
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 17, 2009
Prevalence of coronary artery disease across the Framingham risk categories: coronary artery calcium scoring and MSCT coronary angiographyGaetano Nucifora, Joanne D Schuijf, Jacob M van Werkhoven, et al.
Atherosclerosis|September 18, 2007
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP miceWilleke de Haan, Caroline C van der Hoogt, Marit Westerterp, et al.
Journal of Lipid Research|March 12, 2022
Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analysesDorina Ibi, Manon Boot, Martijn E T Dollé, et al.
European Heart Journal|December 9, 2010
Influence of smoking on the prognostic value of cardiovascular computed tomography coronary angiographyJacob M van Werkhoven, Joanne D Schuijf, Aju P Pazhenkottil, et al.
Chronobiology International|May 16, 2009
Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1Sandrin C Bergheanu, Douwe Pons, J Wouter Jukema, et al.
The American Journal of Cardiology|September 8, 2009
Relation between Framingham risk categories and the presence of functionally relevant coronary lesions as determined on multislice computed tomography and stress testingGaetano Nucifora, Joanne D Schuijf, Jacob M van Werkhoven, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 5, 2005
Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyS Matthijs Boekholdt, Tymen T Keller, Nicholas J Wareham, et al.
Journal of Lipid Research|May 26, 2007
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expressionCaroline C van der Hoogt, Willeke de Haan, Marit Westerterp, et al.
European Heart Journal. Cardiovascular Imaging|December 12, 2018
Referral of patients for fractional flow reserve using quantitative flow ratioJeff M Smit, Gerhard Koning, Alexander R van Rosendael, et al.
Circulation. Genomic and Precision Medicine|April 22, 2021
Genetically Determined Serum Calcium Levels and Markers of Ventricular Repolarization: A Mendelian Randomization Study in the UK BiobankWilliam J Young, Helen R Warren, Dennis O Mook-Kanamori, et al.
Pageof 93

Showing results (401-410 of 927) with videos related to

Sort By:
Pageof 93
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|February 17, 2009
Prevalence of coronary artery disease across the Framingham risk categories: coronary artery calcium scoring and MSCT coronary angiographyGaetano Nucifora, Joanne D Schuijf, Jacob M van Werkhoven, et al.
Atherosclerosis|September 18, 2007
Atorvastatin increases HDL cholesterol by reducing CETP expression in cholesterol-fed APOE*3-Leiden.CETP miceWilleke de Haan, Caroline C van der Hoogt, Marit Westerterp, et al.
Journal of Lipid Research|March 12, 2022
Apolipoprotein A-V is a potential target for treating coronary artery disease: evidence from genetic and metabolomic analysesDorina Ibi, Manon Boot, Martijn E T Dollé, et al.
European Heart Journal|December 9, 2010
Influence of smoking on the prognostic value of cardiovascular computed tomography coronary angiographyJacob M van Werkhoven, Joanne D Schuijf, Aju P Pazhenkottil, et al.
Chronobiology International|May 16, 2009
Myocardial infarction occurs with a similar 24 h pattern in the 4G/5G versions of plasminogen activator inhibitor-1Sandrin C Bergheanu, Douwe Pons, J Wouter Jukema, et al.
The American Journal of Cardiology|September 8, 2009
Relation between Framingham risk categories and the presence of functionally relevant coronary lesions as determined on multislice computed tomography and stress testingGaetano Nucifora, Joanne D Schuijf, Jacob M van Werkhoven, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|February 5, 2005
Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population StudyS Matthijs Boekholdt, Tymen T Keller, Nicholas J Wareham, et al.
Journal of Lipid Research|May 26, 2007
Fenofibrate increases HDL-cholesterol by reducing cholesteryl ester transfer protein expressionCaroline C van der Hoogt, Willeke de Haan, Marit Westerterp, et al.
European Heart Journal. Cardiovascular Imaging|December 12, 2018
Referral of patients for fractional flow reserve using quantitative flow ratioJeff M Smit, Gerhard Koning, Alexander R van Rosendael, et al.
Circulation. Genomic and Precision Medicine|April 22, 2021
Genetically Determined Serum Calcium Levels and Markers of Ventricular Repolarization: A Mendelian Randomization Study in the UK BiobankWilliam J Young, Helen R Warren, Dennis O Mook-Kanamori, et al.
Pageof 93